{
  "_metadata": {
    "version": "1.0.0",
    "description": "Maps activity domains to extraction modules for protocol mining",
    "stage": "Stage 9: Protocol Mining",
    "last_updated": "2025-12-06"
  },
  "domain_module_mappings": {
    "LB": ["laboratory_specifications", "biospecimen_handling"],
    "PC": ["pkpd_sampling", "laboratory_specifications"],
    "PD": ["pkpd_sampling", "endpoints_estimands"],
    "VS": ["safety_monitoring", "adverse_events"],
    "EG": ["safety_monitoring", "endpoints_estimands"],
    "PE": ["safety_monitoring"],
    "AE": ["adverse_events", "sae_reporting", "safety_monitoring"],
    "CM": ["concomitant_medications"],
    "EX": ["investigational_product", "dose_modifications"],
    "DS": ["adverse_events", "dose_modifications"],
    "DM": ["eligibility_criteria", "study_metadata"],
    "MH": ["eligibility_criteria"],
    "FA": ["endpoints_estimands"],
    "QS": ["endpoints_estimands", "pro_specifications"],
    "RS": ["imaging_central_reading", "endpoints_estimands"],
    "TU": ["imaging_central_reading"],
    "TR": ["imaging_central_reading", "endpoints_estimands"],
    "TM": ["imaging_central_reading"],
    "MI": ["imaging_central_reading"],
    "BS": ["biospecimen_handling", "laboratory_specifications"],
    "MB": ["laboratory_specifications"],
    "IS": ["laboratory_specifications"],
    "PP": ["pkpd_sampling"],
    "DA": ["dose_modifications", "investigational_product"],
    "SU": ["concomitant_medications"],
    "SV": ["visit_schedule"],
    "SE": ["visit_schedule"],
    "TA": ["arms_design"],
    "TV": ["visit_schedule", "arms_design"],
    "TI": ["arms_design", "investigational_product"],
    "TE": ["arms_design"]
  },
  "activity_keyword_hints": {
    "hematology": ["laboratory_specifications"],
    "chemistry": ["laboratory_specifications"],
    "urinalysis": ["laboratory_specifications"],
    "cbc": ["laboratory_specifications"],
    "complete blood count": ["laboratory_specifications"],
    "liver function": ["laboratory_specifications"],
    "renal function": ["laboratory_specifications"],
    "coagulation": ["laboratory_specifications"],
    "serum chemistry": ["laboratory_specifications"],
    "lipid panel": ["laboratory_specifications"],
    "thyroid": ["laboratory_specifications"],
    "hba1c": ["laboratory_specifications"],
    "pharmacokinetic": ["pkpd_sampling"],
    "pk sample": ["pkpd_sampling"],
    "pk sampling": ["pkpd_sampling"],
    "drug concentration": ["pkpd_sampling"],
    "pharmacodynamic": ["pkpd_sampling"],
    "biomarker": ["pkpd_sampling", "endpoints_estimands"],
    "ctdna": ["pkpd_sampling", "biospecimen_handling"],
    "circulating tumor": ["pkpd_sampling", "biospecimen_handling"],
    "ecg": ["safety_monitoring", "endpoints_estimands"],
    "electrocardiogram": ["safety_monitoring", "endpoints_estimands"],
    "12-lead ecg": ["safety_monitoring", "endpoints_estimands"],
    "holter": ["safety_monitoring"],
    "vital signs": ["safety_monitoring"],
    "blood pressure": ["safety_monitoring"],
    "physical examination": ["safety_monitoring"],
    "ctcae": ["adverse_events", "safety_monitoring"],
    "adverse event": ["adverse_events"],
    "concomitant medication": ["concomitant_medications"],
    "prior medication": ["concomitant_medications"],
    "tumor assessment": ["imaging_central_reading", "endpoints_estimands"],
    "tumor evaluation": ["imaging_central_reading", "endpoints_estimands"],
    "disease assessment": ["imaging_central_reading", "endpoints_estimands"],
    "response assessment": ["imaging_central_reading", "endpoints_estimands"],
    "recist": ["imaging_central_reading"],
    "irecist": ["imaging_central_reading"],
    "ct scan": ["imaging_central_reading"],
    "ct chest": ["imaging_central_reading"],
    "ct abdomen": ["imaging_central_reading"],
    "mri": ["imaging_central_reading"],
    "mri brain": ["imaging_central_reading"],
    "pet scan": ["imaging_central_reading"],
    "pet-ct": ["imaging_central_reading"],
    "fdg-pet": ["imaging_central_reading"],
    "bone scan": ["imaging_central_reading"],
    "imaging": ["imaging_central_reading"],
    "radiological": ["imaging_central_reading"],
    "radiographic": ["imaging_central_reading"],
    "target lesion": ["imaging_central_reading"],
    "non-target lesion": ["imaging_central_reading"],
    "measurable disease": ["imaging_central_reading"],
    "bicr": ["imaging_central_reading"],
    "blinded independent": ["imaging_central_reading"],
    "central reading": ["imaging_central_reading"],
    "independent review": ["imaging_central_reading"],
    "dlt": ["dose_modifications", "adverse_events"],
    "dose limiting toxicity": ["dose_modifications", "adverse_events"],
    "dose reduction": ["dose_modifications"],
    "dose modification": ["dose_modifications"],
    "dose adjustment": ["dose_modifications"],
    "dose delay": ["dose_modifications"],
    "dose escalation": ["dose_modifications"],
    "dose de-escalation": ["dose_modifications"],
    "dose interruption": ["dose_modifications"],
    "treatment discontinuation": ["dose_modifications", "adverse_events"],
    "qol": ["pro_specifications", "endpoints_estimands"],
    "quality of life": ["pro_specifications", "endpoints_estimands"],
    "patient reported": ["pro_specifications"],
    "pro questionnaire": ["pro_specifications"],
    "eortc": ["pro_specifications"],
    "eq-5d": ["pro_specifications"],
    "sf-36": ["pro_specifications"],
    "fact-g": ["pro_specifications"],
    "biopsy": ["biospecimen_handling"],
    "tissue sample": ["biospecimen_handling"],
    "tumor biopsy": ["biospecimen_handling", "imaging_central_reading"],
    "archival tissue": ["biospecimen_handling"],
    "fresh biopsy": ["biospecimen_handling"],
    "bone marrow": ["biospecimen_handling", "laboratory_specifications"],
    "csf": ["biospecimen_handling", "laboratory_specifications"],
    "cerebrospinal fluid": ["biospecimen_handling", "laboratory_specifications"],
    "genetic testing": ["biospecimen_handling"],
    "pharmacogenomic": ["biospecimen_handling", "pkpd_sampling"],
    "immunogenicity": ["pkpd_sampling", "adverse_events"],
    "ada": ["pkpd_sampling"],
    "anti-drug antibody": ["pkpd_sampling"],
    "pregnancy test": ["laboratory_specifications", "eligibility_criteria"],
    "serum pregnancy": ["laboratory_specifications"],
    "urine pregnancy": ["laboratory_specifications"],
    "informed consent": ["study_metadata"],
    "randomization": ["arms_design"],
    "stratification": ["arms_design"],
    "survival follow-up": ["endpoints_estimands"],
    "overall survival": ["endpoints_estimands"],
    "progression-free survival": ["endpoints_estimands"],
    "time to progression": ["endpoints_estimands"],
    "duration of response": ["endpoints_estimands"],
    "objective response": ["endpoints_estimands", "imaging_central_reading"],
    "complete response": ["endpoints_estimands", "imaging_central_reading"],
    "partial response": ["endpoints_estimands", "imaging_central_reading"],
    "stable disease": ["endpoints_estimands", "imaging_central_reading"],
    "disease control": ["endpoints_estimands", "imaging_central_reading"],
    "progressive disease": ["endpoints_estimands", "imaging_central_reading"]
  },
  "therapeutic_area_modules": {
    "oncology": [
      "imaging_central_reading",
      "dose_modifications",
      "endpoints_estimands",
      "adverse_events",
      "biospecimen_handling"
    ],
    "immunology": [
      "adverse_events",
      "laboratory_specifications",
      "pro_specifications",
      "endpoints_estimands"
    ],
    "cardiology": [
      "safety_monitoring",
      "laboratory_specifications",
      "endpoints_estimands"
    ],
    "neurology": [
      "safety_monitoring",
      "imaging_central_reading",
      "pro_specifications",
      "endpoints_estimands"
    ],
    "infectious_disease": [
      "laboratory_specifications",
      "adverse_events",
      "pkpd_sampling"
    ],
    "rare_disease": [
      "laboratory_specifications",
      "biospecimen_handling",
      "endpoints_estimands",
      "pro_specifications"
    ]
  },
  "module_priority_weights": {
    "laboratory_specifications": 1.0,
    "pkpd_sampling": 1.0,
    "adverse_events": 0.95,
    "imaging_central_reading": 1.0,
    "dose_modifications": 0.95,
    "endpoints_estimands": 0.9,
    "biospecimen_handling": 0.85,
    "safety_monitoring": 0.85,
    "pro_specifications": 0.8,
    "concomitant_medications": 0.75,
    "sae_reporting": 0.7,
    "investigational_product": 0.7,
    "arms_design": 0.65,
    "visit_schedule": 0.6,
    "eligibility_criteria": 0.55,
    "study_metadata": 0.5,
    "data_management": 0.4,
    "site_operations": 0.3
  }
}
